mewburn-logo-white mewburn-logo
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
    • 8 Bishopsgate
    • Residencies
  • en
  • zh-hans
  • germany
  • ja
  • ko
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
    • 8 Bishopsgate
    • Residencies
  • All topics
  • Forward
  • Artificial Intelligence
  • Battery Technologies
  • Bioinformatics
  • Brexit
  • Chemistry
  • Commercial Advice
  • Community
  • COVID-19
  • Designs
  • Energy Storage
  • Engineering
  • EU Unitary Patent / Unified Patent Court
  • FemTech
  • Future Food Tech
  • Future Mobility
  • Graphene & 2D Materials
  • Green Tech
  • ICT
  • Life Sciences
  • Litigation
  • Marine & Ocean Engineering
  • Materials
  • MedTech
  • Microbiome
  • Nature based materials
  • Nuclear
  • On-Demand
  • Oppositions
  • Patents
  • Pharmaceuticals
  • Plants
  • Polymers
  • Polymer recycling
  • Precision Medicine
  • Quantum Computing
  • SME
  • Software
  • Space Tech
  • Synthetic Biology
  • Trade Marks
The Easter Bunny in a white coat — lab-grown chocolate
Nick Sutcliffe - April 17, 2025

The Easter Bunny in a white coat — lab-grown chocolate

As Easter approaches, chocolate takes centre stage. Across the world, people look forward to ...

Oncolytic Virotherapy (OVT) – A Technology Finally Coming of Age?
Nick Sutcliffe - March 3, 2025

Oncolytic Virotherapy (OVT) – A Technology Finally Coming of Age?

The potential of viruses to selectively infect and kill cancer cells was first recognised over a ...

Cellular agriculture – increasing importance of IP in cultivated meat
Nick Sutcliffe - August 13, 2024

Cellular agriculture – increasing importance of IP in cultivated meat

As the cultivated meat industry matures, consolidation is widely anticipated due to increasing ...

Mewburn Ellis ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent Practitioners 2024
Joanna Smith - June 10, 2024

Mewburn Ellis ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent Practitioners 2024

We are delighted to once again be ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent ...

Cellular Agriculture – Innovating through the Challenges
Nick Sutcliffe - March 4, 2024

Cellular Agriculture – Innovating through the Challenges

The last year (2023) has seen a difficult environment for Cellular Agriculture (Cell Ag) companies ...

Covid autumn booster vaccine 2023: the switch to mono-valent vaccines
Nick Sutcliffe - October 3, 2023

Covid autumn booster vaccine 2023: the switch to mono-valent vaccines

Autumn 2023 sees another round of COVID-19 booster jabs across the UK for vulnerable people.

IP priorities for forward-looking cell and gene therapy businesses
Nick Sutcliffe - July 26, 2023

IP priorities for forward-looking cell and gene therapy businesses

IP priorities are especially important to businesses developing advanced therapeutic products. ...

VC tips for SMEs — how much equity should a start-up give away in a Series A fundraising?
Nick Sutcliffe - July 6, 2023

VC tips for SMEs — how much equity should a start-up give away in a Series A fundraising?

As part of a series in which we ask leading venture capitalists to answer a question of fundamental ...

VC tips for SMEs — how to choose the right VC?
Nick Sutcliffe - July 6, 2023

VC tips for SMEs — how to choose the right VC?

As part of a series in which we ask leading venture capitalists to answer a question of fundamental ...

Mewburn Ellis ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent Practitioners 2023
Joanna Smith - July 4, 2023

Mewburn Ellis ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent Practitioners 2023

We are delighted to once again be ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent ...

Cell-cultivated chicken approved for sale in US
Adam Gregory - June 22, 2023

Cell-cultivated chicken approved for sale in US

On Wednesday 21 June 2023, the United States Department of Agriculture (USDA) approved the sale of ...

mRNA cancer vaccine shows efficacy in clinical trial
Nick Sutcliffe - December 20, 2022

mRNA cancer vaccine shows efficacy in clinical trial

Moderna and Merck announced in a mid-December 2022 press release that its mRNA cancer vaccine ...

Mewburn Ellis ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent Practitioners 2022
Jacqueline Murphy - July 4, 2022

Mewburn Ellis ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent Practitioners 2022

We are delighted to once again be ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent ...

Mewburn Ellis ranked Tier 1 for Patent prosecution in MIP IP STARS 2022
Jacqueline Murphy - June 20, 2022

Mewburn Ellis ranked Tier 1 for Patent prosecution in MIP IP STARS 2022

We are delighted to once again be ranked Tier 1 for Patent Prosecution UK in MIP IP STARS 2022.

IAM Patent 1000: The World’s Leading Patent Professionals 2021
Jacqueline Murphy - July 2, 2021

IAM Patent 1000: The World’s Leading Patent Professionals 2021

We are delighted to once again be ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent ...

Mewburn Ellis ranked Tier 1 for Patent prosecution in MIP IP STARS 2021
Jacqueline Murphy - June 17, 2021

Mewburn Ellis ranked Tier 1 for Patent prosecution in MIP IP STARS 2021

We are delighted to be ranked Tier 1 for Patent Prosecution UK in MIP IP STARS 2021. As one of only ...

IP for forward-looking life sciences businesses
Nick Sutcliffe - May 14, 2021

IP for forward-looking life sciences businesses

The recently released Mewburn Ellis IP Guide for SMEs sets out IP priorities for businesses at four ...

AstraZeneca/Oxford University vaccine shows efficacy against SARS-CoV-2
Nick Sutcliffe - November 25, 2020

AstraZeneca/Oxford University vaccine shows efficacy against SARS-CoV-2

AstraZeneca/Oxford University have announced that their SARS-CoV-2 candidate vaccine AZD1222 showed ...

And then there were two – Moderna SARS-CoV-2 vaccine shows efficacy
Nick Sutcliffe - November 16, 2020

And then there were two – Moderna SARS-CoV-2 vaccine shows efficacy

Moderna have announced that their SARS-CoV-2 vaccine candidate mRNA1273 showed efficacy in a first ...

Pfizer and BioNTech vaccine provides protection against SARS-CoV-2
Nick Sutcliffe - November 13, 2020

Pfizer and BioNTech vaccine provides protection against SARS-CoV-2

Pfizer/BioNTech have now released more data from the Phase 3 clinical trial of the BNT162b2 ...

Liquid biopsies support precision medicine
Nick Sutcliffe - October 21, 2020

Liquid biopsies support precision medicine

The treatment of cancer patients with therapies that are specifically targeted to their cancer is a ...

Making the detection of cancer in liquid biopsies more sensitive
Nick Sutcliffe - September 22, 2020

Making the detection of cancer in liquid biopsies more sensitive

Besides being found within the nucleus and mitochondria of cells, DNA is also present in ...

Pepper decision means conventionally bred plants and animals get a chilli reception at the EPO
Nick Sutcliffe - September 11, 2020

Pepper decision means conventionally bred plants and animals get a chilli reception at the EPO

Dr Ben Tolley and Dr Nick Sutcliffe of the Life Sciences team look at the extensive ramifications ...

Supreme Court confirms strict line on insufficiency in the UK
Nick Sutcliffe - June 29, 2020

Supreme Court confirms strict line on insufficiency in the UK

On 24 June 2020, the UK Supreme Court (UKSC) confirmed the UK courts’ strict approach to sufficient ...

IAM Patent 1000: The World’s Leading Patent Professionals 2020
Jacqueline Murphy - June 16, 2020

IAM Patent 1000: The World’s Leading Patent Professionals 2020

We are delighted to once again be ranked ‘highly recommended’ in ‘IAM 1000: The World’s Leading ...

G3/19 The Enlarged Board of Appeal has its cake and eats it
Nick Sutcliffe - May 19, 2020

G3/19 The Enlarged Board of Appeal has its cake and eats it

On 14 May 2020, the Enlarged Board of Appeal of the European Patent Office (EBA) released their ...

IP STARS 2020: The leading practitioners in IP
Jacqueline Murphy - May 5, 2020

IP STARS 2020: The leading practitioners in IP

Congratulations to Sofia Arenal, Chris Denison, Stephen Gill, Sean Jauss, Kate O’Rourke, Nick ...

The evolutionary history of cancer - predicting the disease
Nick Sutcliffe - February 18, 2020

The evolutionary history of cancer - predicting the disease

Cells can acquire the mutations that drive the development of cancer many years before the patient ...

Controlling genes – the new field of epitranscriptomics
Nick Sutcliffe - October 21, 2019

Controlling genes – the new field of epitranscriptomics

The human genome contains roughly 20,000 genes that encode proteins. In order for the cells and ...

Shifting treatments: cancer as a manageable disease
Nick Sutcliffe - August 29, 2019

Shifting treatments: cancer as a manageable disease

As new treatments drive a shift towards treating cancer as a manageable disease we are seeing ...

Managing Intellectual Property: IP Stars 2019
Jacqueline Murphy - June 17, 2019

Managing Intellectual Property: IP Stars 2019

We are delighted to be ranked in Managing Intellectual Property: IP Stars for 2019.

IAM Patent 1000, 2019
Jacqueline Murphy - June 17, 2019

IAM Patent 1000, 2019

We are delighted to be ranked highly recommended in ‘IAM 1000: The World’s Leading Patent ...

Supreme Court decision signals bad news for patent holders
Nick Sutcliffe - November 14, 2018

Supreme Court decision signals bad news for patent holders

The UK Supreme Court issued its decision today on the Warner Lambert vs Generics (UK) Ltd t/a ...

More

  • Slavery Act
  • Legal Notices
  • Terms and Conditions
  • Privacy
  • Forward Community Programme
  • Client Login
  • Join Mewburn Ellis

Follow us

Subscribe

Sign up to Forward: news, insights and features from Mewburn Ellis

Contact

  • mail@mewburn.com
  • London:

    +44 (0)20 7776 5300
  • Bristol:

    +44 (0)117 945 1234
  • Cambridge:

    +44 (0)1223 420383
  • Manchester:

    +44 (0)161 2477 722
  • Munich:

    +49 (0)89 244 459800

Copyright © 2025 Mewburn Ellis. All rights reserved. Terms and Conditions & Online Privacy